Helsinnreimbursement.com Recently Analyzed

Home » Helsinnreimbursement.com

Helsinnreimbursement.com has a Worldwide ranking of n/a Down n/a and ranking n/a in n/a. Using IP address 162.13.154.248 in and found 0 Other Websites on this Server

The site's up time is: 151 ms

Domain Age: 2 years, 209 days (Creation Date: 2016-11-22)

Similar Webs


Check the markup (HTML, XHTML,...) of Helsinnreimbursement.com

Validate Now

  • Domain: Helsinnreimbursement.com
  • Hostname: 162.13.154.248
  • Name Servers:

    1: ns.barbero.uk

    2: ns.barbero.eu

    3: ns.barbero.de

    4: ns.barbero.us

    5: ns.barbero.asia

  • Email Abuse:

    No Emails

  • Continent Code: EU
  • Country Code: GB
  • Country Code3: GBR
  • Country Name: United Kingdom
  • Region:
  • City:
  • Postal Code:
  • Latitude: 51.496398925781
  • Longitude: -0.12240000069141
  • Dma Code: 0
  • Area Code: 0

Analyzed Recently

  › Matrixmls.com (1 seconds ago)

  › Skatelynwood.com (3 seconds ago)

  › Hucompute.org (1 seconds ago)

  › Cartmelvalleygamesupplies.com (3 seconds ago)

  › Centralfloridalincoln.com (4 seconds ago)

  › Talpasonicdrilling.com (5 seconds ago)

  › Itlpublicschool.net (1 seconds ago)

  › Drmaurilunderman.com (3 seconds ago)

  › Acespottertrucksforsale.com (2 seconds ago)

  › Chrgweb.com (1 seconds ago)

  › Helsinnreimbursement.com (1 seconds ago)

  › Stonesshell.com (0 seconds ago)

  › Mecanizar.com (1 seconds ago)

  › Aspmnmd.com (3 seconds ago)

  › Criminaldefensenorthampton.com (1 seconds ago)

  › Tatar.run (1 seconds ago)

  › Stbenedictcrystalriver.org (1 seconds ago)

  › Igt.com (3 seconds ago)

  › Casadecora.net (3 seconds ago)

  › Fanbasedigital.com (3 seconds ago)

Keywords Suggestions

  › Helsinn reimbursement

MetaTags & Keyword Analysis

Websites Listing Results

Helsinnreimbursement.com search for results as listed below with the link list and email address for this website

Helsinn Cares | Healthcare Reimbursement Support & Resources

Helsinn Cares is a program dedicated to providing access to healthcare resources for patients and reimbursement support for healthcare professionals.

Link: https://helsinnreimbursement.com/ (Actived: Monday Jun 17, 2019)

AKYNZEO® Capsule Savings Program & Other Resources | AKYNZEO®

Important Safety Information Warnings and Precautions. Hypersensitivity reactions, including anaphylaxis, have been reported in patients receiving palonosetron, one of the components of AKYNZEO, with or without known hypersensitivity to other 5-HT 3 receptor antagonists.; Serotonin syndrome has been reported with 5-HT 3 receptor antagonists alone but particularly with concomitant use of

Link: https://www.akynzeo.com/hcp/access-and-reimbursement (Actived: Saturday Jun 15, 2019)

Helsinn Cares - FLASCO Patient Portal

Helsinn Cares is committed to providing healthcare professionals, patients, and caregivers with the resources and information needed for access and reimbursement support.

Link: http://patients.flasco.org/patientresources/helsinn-cares/ (Actived: Wednesday Jun 12, 2019)

Helsinnreimbursement Competitive Analysis, Marketing Mix ...

What marketing strategies does Helsinnreimbursement use? Get traffic statistics, SEO keyword opportunities, audience insights, and competitive analytics for Helsinnreimbursement.

Link: https://www.alexa.com/siteinfo/helsinnreimbursement.com (Actived: Monday Jun 3, 2019)

Akynzeo Copay Card

Eligibility Criteria: Good toward the purchase of AKYNZEO Capsule prescriptions. No substitutions permitted. Save the card to reuse with each prescription. Not available to patients enrolled in state or federal healthcare programs, including Medicare, Medicaid, Medigap, VA, DoD or TRICARE.

Link: https://www.akynzeosavingsprogram.com/ (Actived: Friday Jun 14, 2019)

Helsinn Group Announces new Permanent J Code for AKYNZEO ...

Akynzeo ® for injection received a permanent J code, J1454, in the US, by the Centers for Medicare and Medicaid Services ; Lugano, Switzerland, December 12th, 2018 – Helsinn, a Swiss pharmaceutical group, today announces that Akynzeo ® for injection has been assigned the new permanent J code, J1454, in the US by the Centers for Medicare and Medicaid Services (CMS), effective January 1, 2019.

Link: https://www.helsinn.com/news-and-events/helsinn-group-announces-new-permanent-j-code-for-akynzeo-fosnetupitant-and-palonosetron-for-injection-in-the-us/ (Actived: Saturday Jun 15, 2019)

Prevention of chemo-induced nausea vomiting (CINV), made ...

By Francois LaFleur, Vice President Medical Affairs at Helsinn Therapeutics f the nearly 1.7 Americans who are expected to receive a cancer diagnosis this year1, an estimated 650,000 of them will

Link: https://www.statnews.com/sponsor/2017/05/24/complexities-preventing-chemo-induced-nausea-vomiting-cinv-made-easy-patients/ (Actived: Tuesday May 23, 2017)

Helsinn Group Announces new Permanent J Code for AKYNZEO ...

Lugano, Switzerland, December 12, 2018 – Helsinn, a Swiss pharmaceutical group, today announces that Akynzeo ® for injection has been assigned the new permanent J code, J1454, in the US by the

Link: https://www.globenewswire.com/news-release/2018/12/12/1665839/0/en/Helsinn-Group-Announces-new-Permanent-J-Code-for-AKYNZEO-fosnetupitant-and-palonosetron-for-injection-in-the-US.html (Actived: Wednesday Dec 12, 2018)

Helsinn Therapeutics | Oncology Practice Management

Helsinn Therapeutics offers the Helsinn Cares program that supports access, reimbursement, and assistance for patients who are prescribed Akynzeo (netupitant and palonosetron) or Valchlor (mechlor­ethamine gel). Akynzeo is indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV). Valchlor is indicated for the topical treatment of stage IA/IB mycosis

Link: http://oncpracticemanagement.com/pssguide2019/helsinn-therapeutics/ (Actived: Saturday Jun 15, 2019)

Patient Resource Publishing : Financial Resources

Financial Resources & Pharmaceutical Assistance. Below are the names and contact information of organizations that offer financial assistance to people affected by cancer, or that have links to organizations that may provide such help.

Link: http://www.patientresource.com/Financial_Resources.aspx (Actived: Friday Jun 14, 2019)

Helsinn Group Announces new Permanent J Code for AKYNZEO ...

Helsinn Group Announces new Permanent J Code for AKYNZEO ® (fosnetupitant and palonosetron) for injection in the US. Akynzeo ® for injection received a permanent J code, J1454, in the US, by the Centers for Medicare and Medicaid Services ; Lugano, Switzerland, December 12, 2018 – Helsinn, a Swiss pharmaceutical group, today announces that Akynzeo ® for injection has been assigned the new

Link: https://www.ptcommunity.com/wire/helsinn-group-announces-new-permanent-j-code-akynzeo-fosnetupitant-and-palonosetron-injection (Actived: Tuesday May 28, 2019)